@article{ad8538cf06b741bca27862c42142b6f8,
title = "Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in african americans",
abstract = "A small proportion of human immunodeficiency virus-1 (HIV-1) infected individuals, termed HIV-1 controllers, suppress viral replication to very low levels in the absence of therapy. Genetic investigations of this phenotype have strongly implicated variation in the class I major histocompatibility complex (MHC) region as key to HIV-1 control. We collected sequence-based classical class I HLA genotypes at 4-digit resolution in HIV-1-infected African American controllers and progressors (n = 1107), and tested them for association with host control using genome-wide single nucleotide polymorphism data to account for population structure. Several classical alleles at HLA-B were associated with host control, including B*57:03 [odds ratio (OR) = 5.1; P = 3.4 × 10-18] and B*81:01 (OR = 4.8; P = 1.3 × 10-9). Analysis of variable amino acid positions demonstrates that HLA-B position 97 is the most significant association with host control in African Americans (omnibus P = 1.2 × 10-21) and explains the signal of several HLA-B alleles, including B*57:03. Within HLA-B, we also identified independent effects at position 116 (omnibus P = 2.8 × 10-15) in the canonical F pocket, position 63 in the B pocket (P = 1.5 × 10-3) and the non-pocket position 245 (P = 8.8 × 10-10), which is thought to influence CD8-binding kinetics. Adjusting for these HLA-B effects, there is evidence for residual association in the MHC region. These results underscore the key role of HLA-B in affecting HIV-1 replication, likely through the molecular interaction between HLA-B and viral peptides presented by infected cells, and suggest that sites outside the peptide-binding pocket also influence HIV-1 control.",
author = "{The International HIV Controllers Study} and McLaren, {Paul J.} and Stephan Ripke and Kimberly Pelak and Weintrob, {Amy C.} and Patsopoulos, {Nikolaos A.} and Xiaoming Jia and Erlich, {Rachel L.} and Lennon, {Niall J.} and Kadie, {Carl M.} and David Heckerman and Namrata Gupta and Haas, {David W.} and Deeks, {Steven G.} and Florencia Pereyra and Walker, {Bruce D.} and {de Bakker}, {Paul I.W.} and Kuritzkes, {Daniel R.} and Robbins, {Gregory K.} and Shafer, {Robert W.} and Gulick, {Roy M.} and Shikuma, {Cecilia M.} and Richard Haubrich and Sharon Riddler and Sax, {Paul E.} and Daar, {Eric S.} and Ribaudo, {Heather J.} and Addo, {Marylyn M.} and Brian Agan and Shanu Agarwal and Ahern, {Richard L.} and Allen, {Brady L.} and Sherly Altidor and Altschuler, {Eric L.} and Sujata Ambardar and Kathryn Anastos and Val Anderson and Ushan Andrady and Diana Antoniskis and David Bangsberg and Daniel Barbaro and William Barrie and J. Bartczak and Simon Barton and Patricia Basden and Nesli Basgoz and Bellos, {Nicholaos C.} and Judith Berger and Bernard, {Nicole F.} and Bernard, {Annette M.} and Jason Okulicz",
note = "Funding Information: Additional support for this work was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. Funding Information: This work was made possible through a generous donation from the Mark and Lisa Schwartz Foundation and a subsequent award from the Collaboration for AIDS Vaccine Discovery (CAVD) of the Bill and Melinda Gates Foundation. This work was also supported in part by the Harvard University Center for AIDS Research (P-30-AI060354), UCSF CFAR (P-30 AI27763), UCSF CTSI (UL1 RR024131), CNICS (R24 AI067039), Vanderbilt CTSA (RR024975), NIH grants AI28568, AI030914 (B.D.W.); AI087145, K24AI069994 (S.G.D.); AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI68634, AI069502, AI069419, AI068636, RR024975 (AIDS Clinical Trials Group); AI077505 and MH071205 (D.W.H.). S.R. acknowledges support from NIH/ NIMH (MH085520).",
year = "2012",
month = jan,
day = "1",
doi = "10.1093/hmg/dds226",
language = "English",
volume = "21",
pages = "4334--4347",
journal = "Human Molecular Genetics",
issn = "0964-6906",
number = "19",
}